Yulun Wang, Head of Research & Development at Teladoc Health, Inc. (TDOC), sold 6,069 shares at $198.00 ($1.2M) on 2020-12-04, disclosed to the SEC on 2020-12-07.
Open-market sale of $1.2M TDOC by Head of Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $198.00 | 1,069 | $212K | 17.3% |
| 2 | $202.00 | 5,000 | $1.0M | 82.7% |
| Total | $201.30 avg | 6,069 | $1.2M | 100% |
| Filing → |
| TDOC | SELL | 2021-01-22 | $1.9M | — | Filing → |
| TDOC | SELL | 2021-01-19 | $1.8M | — | Filing → |
| TDOC | SELL | 2020-12-16 | $498K | — | Filing → |